“…A crucial part of COVID-19 patients with ARDS presents an excess pro-inflammatory cytokine release, which may be related to cytokine storm syndrome in the respiratory system [4]. It has been shown that many patients with COVID-19 had increased serum levels of pro-inflammatory cytokines such as IL-6, IL-1β, IL-2, IL-8, IL-17, granulocyte-colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, and TNF-α [5,15]. However, corticosteroids and other immunosuppressant agents have not been encouraged in COVID-19 because of their given deteriorating effects to already vulnerable respiratory tract [6].…”